Chris Paschall, Director, Technology Partnerships, Business Development & Licensing & Open Innovation, Bayer
Chris Paschall, Ph.D., CLP, RTTP, is the Director of Technology Partnerships in the Open Innovation Center at Bayer where he is responsible for managing multiple research alliances and engaging in the early-stage ecosystem. Prior to joining Bayer in November 2020, Chris was the Executive Director of Licensing at The Ohio State University’s Technology Commercialization Office (TCO), a Licensing Manager for the University of Virginia Licensing & Ventures Group, a Licensing Associate in the Emory Office of Technology Transfer and a Licensing Associate at the U.Va. Patent Foundation. In 2008, he became a registered patent agent with the U.S. Patent and Trademark Office, in 2010, he became a Certified Licensing Professional, and in 2018, he became a Registered Technology Transfer Professional. Chris has nearly fifteen years commercializing technologies in pharmaceuticals, biotech, medical devices, and engineering, having negotiated almost 200 licensing deals, including four of the five largest licensing transactions ever executed at The Ohio State University. Chris received his doctorate in biomedical engineering from the University of Virginia, where his research focused on leukocyte adhesion in inflammatory responses and its application to targeted drug delivery, as well as his bachelor of science in chemical engineering, also from the University of Virginia.